Trial Profile
Effect of three drug combination containing bortezomib and dexamethasone versus bortezomib and dexamethasone alone in patients with myeloma and severe renal impairment
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 May 2015
Price :
$35
*
At a glance
- Drugs Bortezomib (Primary) ; Dexamethasone (Primary)
- Indications Multiple myeloma; Renal impairment
- Focus Therapeutic Use
- 12 May 2015 New trial record